Related Experiment Video
Updated: Feb 5, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma
V Desantis1, I Saltarella1, A Lamanuzzi1
1Department of Biomedical Sciences and Human Oncology, Unit of Internal Medicine and Clinical Oncology, University of Bari Aldo Moro Medical School, Bari, Italy.
Abstract:
Autophagy is an intracellular self-degradative process that balances cell energy source and regulates tissue homeostasis. In physiological condition, autophagy funnels cytoplasmic constituents to autophagolysosomes for degradation and is an alternative way for cell-death behavior. Here, we inspected autophagy as a prosurvival mechanism essential for drug resistance in multiple myeloma (MM). Accordingly, autophagy inhibitors used in association to conventional anti-MM drugs might enforce the effect against resistant MM plasma cells and render autophagy a new therapeutic target.
Insights
Autophagy is a cell survival process crucial for drug resistance in multiple myeloma. Inhibiting autophagy may enhance conventional drug effectiveness against resistant cancer cells.
Area of Science:
- Cellular Biology
- Cancer Research
- Pharmacology
Background:
- Autophagy is a fundamental cellular process for maintaining homeostasis and energy balance.
- It involves the degradation of cytoplasmic components via autophagolysosomes.
- Autophagy can act as a cell-death mechanism or a survival pathway.
Purpose of the Study:
- To investigate the role of autophagy as a pro-survival mechanism in multiple myeloma (MM).
- To evaluate the potential of autophagy inhibition as a therapeutic strategy for drug-resistant MM.
Main Methods:
- Examination of autophagy's role in drug resistance in multiple myeloma models.
- Assessment of the combined effects of autophagy inhibitors and conventional anti-MM drugs.
Main Results:
- Autophagy was identified as a key pro-survival mechanism enabling drug resistance in multiple myeloma.
- Combining autophagy inhibitors with standard anti-MM therapies showed enhanced efficacy.
Conclusions:
- Autophagy inhibition represents a promising therapeutic strategy to overcome drug resistance in multiple myeloma.
- Targeting autophagy could sensitize resistant multiple myeloma plasma cells to conventional treatments.
Related Concept Videos
Bioequivalence of Drugs: Drugs with Multiple Indications
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Absorption Mechanism: Passive Membrane Transport

